Western blot
0.2-1 ug/mlELISA Titer: 1:62500Positive Control: PANC1 cell lysate| Product Name | Rabbit anti-BACE2 polyclonal antibody - N-terminal region |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | AEPLC, ALP56, ASP1, ASP21, BAE2, CDA13, CEAP1, DRAP |
| Immunogen | The immunogen for anti-BACE2 antibody: synthetic peptide directed towards the N terminal of human BACE2 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:500~1:2000 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | Guinea PigHumanMousePigRat |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Symbol | BACE2 |
|---|---|
| Gene Synonyms | AEPLC ALP56 ASP1 ASP21 BAE2 CDA13 CEAP1 DRAP |
| Gene Full Name | Beta-site APP-cleaving enzyme 2 |
| Gene Summary | Cerebral deposition of amyloid beta peptide is an early and critical feature of Alzheimer's disease and a frequent complication of Down syndrome. Amyloid beta peptide is generated by proteolytic cleavage of amyloid precursor protein by 2 proteases, one of which is the protein encoded by this gene. This gene localizes to the 'Down critical region' of chromosome 21. The encoded protein, a member of the peptidase A1 protein family, is a type I integral membrane glycoprotein and aspartic protease. Three transcript variants encoding different isoforms have been described for this gene. |
| Alternative Names | AEPLC ALP56 ASP1 ASP21 BAE2 CDA13 CEAP1 DRAP |
| Molecular Weight(MW) | 37kDa |
| Sequence | 396 amino acids |
Western blot
0.2-1 ug/mlELISA Titer: 1:62500Positive Control: PANC1 cell lysate| Application Notes | WB:1:500~1:2000 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles |
| Storage Buffer | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
